The appeal of AI in medicine is rooted in its ability to process information at a scale no individual clinician can match. Modern health care generates enormous quantities of data, including electronic health records, laboratory measurements, medication histories, medical images, genetic sequences, wearable-device signals and clinical notes. Machine-learning systems can analyze these data rapidly, identify statistical patterns and generate predictions about diagnosis, prognosis or treatment response. In imaging, neural networks can be trained to recognize subtle features associated with cancer, retinal disease or neurological injury. In clinical documentation, large language models can summarize records, draft notes and extract relevant information from thousands of pages. These capabilities could reduce delays and help clinicians detect signals that might otherwise be overlooked.

AI systems may also make medical expertise more continuously available. A physician can examine only a limited number of patients at a time, while software can operate around the clock and support millions of interactions simultaneously. Automated tools could answer routine questions, monitor chronic conditions, remind patients about medications and identify changes that warrant professional attention. For people living in regions with few doctors, algorithmic systems might provide preliminary guidance or help local health workers interpret complex cases. In principle, AI could also reduce costs by automating repetitive administrative work, allowing physicians to spend more time on diagnosis, communication and treatment decisions. The technology’s greatest value may therefore come not from replacing clinical encounters but from extending the reach of scarce medical expertise.

Yet speed and scale do not guarantee safe or appropriate care. AI models learn from existing data, and those data reflect the strengths, weaknesses and inequities of the health systems that produced them. If a training dataset contains fewer examples from particular racial, ethnic, socioeconomic or geographic groups, an algorithm may perform less accurately for those patients. A model developed in one hospital may fail when deployed in another because patient populations, equipment, documentation practices and disease prevalence differ. This problem, known as distribution shift, can cause performance to deteriorate when real-world conditions depart from the environment in which the system was trained. Continuous monitoring, external validation and recalibration are therefore essential, but they are technically demanding and often neglected after deployment.

AI also introduces distinctive forms of error. A language model can produce fluent but false statements, a phenomenon commonly called hallucination. A diagnostic algorithm may be highly accurate on average while making dangerous mistakes in unusual cases. Some systems provide a probability without explaining the biological or clinical reasoning behind it, making it difficult for a physician or patient to challenge the recommendation. Other models can be influenced by irrelevant details, such as differences in image quality or wording in a clinical note. Automation bias adds another risk: people may accept a computer-generated recommendation simply because it appears objective or technologically sophisticated. In medicine, an incorrect answer delivered with confidence can be more hazardous than an acknowledged uncertainty.

Physician-led care has limitations of its own. Doctors vary in knowledge, experience, attention and susceptibility to cognitive biases. Fatigue, time pressure and excessive workloads can contribute to diagnostic mistakes, delayed follow-up and communication failures. Human clinicians may also rely too heavily on familiar patterns, overlook rare conditions or recommend treatments inconsistently. Medical care can be expensive and difficult to access, particularly for patients who live far from hospitals or lack insurance. Physicians cannot memorize every new study, guideline or drug interaction, and no doctor can independently review all the information available in a complex patient record. These constraints explain why AI tools are attractive even to clinicians who remain cautious about autonomous medical decision-making.

The central distinction is not simply between human intelligence and artificial intelligence, but between different kinds of judgment. Physicians can interpret a patient’s goals, fears, family circumstances and tolerance for risk in ways that remain difficult to encode mathematically. They can notice when a patient’s words, behavior or silence suggests distress, confusion or mistrust. They can negotiate competing values, explain uncertainty and accept responsibility for a recommendation. These interpersonal and ethical dimensions are not peripheral to medicine; they influence whether patients understand a diagnosis, follow a treatment plan and feel respected. AI can imitate empathy through language, but imitation does not necessarily equal comprehension, moral responsibility or a genuine therapeutic relationship.

A safer model may be collaborative care in which algorithms perform narrowly defined tasks while physicians retain meaningful oversight. In such a system, AI might screen images, identify medication interactions, compare a patient’s data with relevant evidence or alert clinicians to a deteriorating condition. The physician would evaluate the output in context, discuss options with the patient and decide whether the recommendation is appropriate. This arrangement, however, requires more than placing a software tool inside a hospital. Clinicians must be trained to understand model limitations, interpret confidence scores and recognize when an algorithm is operating outside its validated range. Health systems also need clear rules for documenting AI involvement, investigating errors and determining responsibility when automated advice contributes to harm.

The expansion of AI care raises broader questions about accountability, privacy and the future medical workforce. Training powerful models requires access to sensitive health information, creating risks if data are collected without meaningful consent or protected inadequately. Commercial systems may be difficult to audit if their developers treat model architecture or training data as proprietary. Patients may not know whether they are communicating with a person or a machine, or how their information will be used to improve the system. At the same time, widespread automation could change the skills expected of physicians, shifting emphasis from memorization toward verification, communication, systems thinking and ethical reasoning. The Perspective in JAMA presents this debate as a choice with no effortless answer: AI may improve accuracy, access and efficiency, but medicine’s human obligations cannot be reduced to prediction alone. The future of care will depend on whether technological power is placed under effective clinical, ethical and public oversight.

Subject of Research: The advantages and disadvantages of physician-led medical care compared with medical care provided by artificial intelligence.

Web References: https://doi.org/10.1001/jama.2026.15380

References: Emanuel EJ. Perspective on physician-led medical care versus artificial intelligence–provided medical care. JAMA. doi:10.1001/jama.2026.15380.

Keywords

Artificial intelligence; AI in medicine; physician-led care; health care; clinical decision-making; machine learning; medical ethics; diagnostic accuracy; patient safety; health equity.

Embryo classification is a vital process in assisted reproductive technology (ART), where the success of in vitro fertilization (IVF) hinges on the quality of embryos. Traditional methods have relied heavily on the expertise of embryologists, who manually assess embryo viability based on morphological criteria. However, these subjective evaluations often lead to inconsistent outcomes, highlighting the need for a more objective and systematic approach. The EmbryoNet-VGG16 framework offers a solution to this pressing challenge by harnessing the power of deep learning algorithms.

Deep learning, a subset of machine learning characterized by neural networks, enables computers to learn from vast amounts of data. The VGG16 model, known for its depth and architecture, has been pivotal in the domain of image recognition. By adapting this model for embryo classification, Saraniya and Ruth aim to enhance the accuracy of identifying viable embryos. The integration of Otsu segmentation further refines this process by selecting the optimal threshold for distinguishing embryo structures in images, thereby improving segmentation quality and classification performance.

The study underscores the critical role of image processing techniques in medical applications. Otsu’s method, a thresholding technique developed by Nobuyuki Otsu in 1979, is widely recognized for its effectiveness in separating objects within images. The researchers have demonstrated that incorporating Otsu segmentation into the embryo classification process significantly reduces noise and enhances the clarity of the embryonic features being analyzed. This methodological enhancement is pivotal in training the VGG16 model to deliver more reliable classifications.

One of the standout features of the EmbryoNet-VGG16 framework is its capacity to learn from and adapt to large datasets. The study involved training the model on a comprehensive dataset of embryo images, which not only facilitates better recognition patterns but also allows the model to generalize its findings to new, unseen data. This aspect is crucial, particularly in the medical field, where variability is often encountered due to differences in imaging techniques, equipment, and embryo characteristics.

Moreover, the research involved rigorous evaluations and comparisons against existing classification techniques, showcasing the superior performance metrics of the proposed framework. The results indicated a marked improvement in accuracy rates, confirming that the EmbryoNet-VGG16 model can effectively detect viable embryos compared to conventional classification methods. This level of precision has far-reaching implications for ART, as it could potentially optimize the selection process, leading to higher success rates in IVF treatments.

Beyond mere accuracy, the framework’s scalability and adaptability offer promising aspects for future research. As more extensive datasets become available, the potential to refine the model further and enhance its classification capabilities is a tantalizing prospect. Additionally, given the broad applicability of deep learning in various medical domains, insights gleaned from this study may pave the way for the development of similar frameworks in other areas, such as oncology and cardiology.

The EmbryoNet-VGG16 framework not only enhances the classification process but also highlights the growing trend of interdisciplinary collaboration between computer science and reproductive medicine. The need for a cross-functional approach underlines that the future of healthcare relies on integrating advanced technologies with traditional medical practices. This study stands as a testament to these possibilities, showcasing how artificial intelligence can be leveraged to solve complex biological problems.

In terms of practical applications, the significance of this research is manifold. Clinics utilizing assisted reproductive technologies could incorporate the EmbryoNet-VGG16 framework to streamline their embryo selection processes, resulting in better efficiency and outcomes for patients. The potential for reducing the emotional and financial burdens associated with IVF is monumental, aligning healthcare practices more closely with patient needs and expectations.

However, the journey does not end here. The study opens up several avenues for future exploration. One intriguing direction is the exploration of transfer learning, whereby knowledge from the EmbryoNet-VGG16 model can be applied to different classification tasks. Researchers are excited about the prospects of continually improving and evolving the model as new techniques and insights into deep learning emerge.

Ethical considerations also emerge from this technological advancement. As AI assumes a larger role in decision-making processes traditionally governed by human expertise, questions of accountability and transparency arise. It is imperative that as the EmbryoNet-VGG16 framework is integrated into clinical settings, clear protocols and guidelines are established to navigate the moral landscape of AI in healthcare.

In summary, the EmbryoNet-VGG16 framework represents a watershed moment in the intersection of deep learning and reproductive technology. By applying sophisticated algorithms to the nuanced task of embryo classification, this research not only advances the field of ART but also serves as a landmark study in realizing the full potential of AI in medicine. As the scientific community continues to explore the implications and applications of this work, the excitement surrounding its findings illuminates the promise of a future where AI and human expertise harmoniously coexist in pursuit of enhanced healthcare outcomes.

Subject of Research: Embryo classification using deep learning and Otsu segmentation.

Article Title: EmbryoNet-VGG16 framework for deep learning-based embryo classification with Otsu segmentation.

Article References:

Saraniya, M., Ruth, J.A. EmbryoNet-VGG16 framework for deep learning-based embryo classification with Otsu segmentation.
Discov Artif Intell 5, 194 (2025). https://doi.org/10.1007/s44163-025-00445-z

Image Credits: AI Generated

DOI: 10.1007/s44163-025-00445-z

Keywords: Deep learning, embryo classification, Otsu segmentation, reproductive technology, artificial intelligence, VGG16 model.